Decoding the Gene Editing Sector and Focusing on Progress and Investment Perspectives of Three Leading Companies Jan 21, 2026 Life Science
Massive Upside Potential: Two Canadian Growth Stocks for Risk-Tolerant Investors Jan 21, 2026 Life Science, Precious Metals
GSK to Acquire RAPT Therapeutics for $2.2 Billion, Bolstering Food Allergy Pipeline Jan 20, 2026 Life Science
The Long-Term Investment Value of Eli Lilly, AbbVie, and Intuitive Surgical Jan 20, 2026 Life Science
NVIDIA and Eli Lilly Team Up to Open a New Chapter in AI-Driven Drug Development Jan 16, 2026 Life Science, Technology
Forward P/E Highlights Undervalued Growth Opportunities in ABBV, MU and ADBE Jan 15, 2026 Life Science, Technology
ImmunityBio Soars Over 30% as Bladder Cancer Drug Anktiva Delivers Breakout Growth Jan 15, 2026 Life Science
Three Promising Healthcare Stocks Poised to Maintain Their Leadership Position Jan 14, 2026 Life Science
Eli Lilly and Novo Nordisk: The Battle for Dominance in the 2026 Weight-Loss Drug Market Jan 13, 2026 Life Science
Tempus AI: Why Cross-Sector Investors Are Eyeing This Unique Healthcare Data Play? Jan 12, 2026 Life Science, Technology
Medline’s Stock Price Soars After Market Debut, Wall Street Bullish on the “Aging Dividend” Jan 12, 2026 Life Science
